Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 468781 - 468800 out of 476556 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XL02) talimogene laherparepvec | IMLYGIC /1MPFU/ML | 1M | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | AmgenUSA,Inc. |
USA | (L01XL02) talimogene laherparepvec | IMLYGIC /1MPFU/ML | 1M | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | AmgenUSA,Inc. |
USA | (L01XL02) talimogene laherparepvec | IMLYGIC/100MPFU/ML | 100M | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | AmgenUSA,Inc. |
USA | (L01XL02) talimogene laherparepvec | IMLYGIC/100MPFU/ML | 100M | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | AmgenUSA,Inc. |
USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
USA | (L01XL05) ciltacabtagene autoleucel | CARVYKTI | 70ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XL05) ciltacabtagene autoleucel | CARVYKTI | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XL05) ciltacabtagene autoleucel | CARVYKTI | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XL05) ciltacabtagene autoleucel | CARVYKTI | 70ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01XL06) brexucabtagene autoleucel | TECARTUS INFUSION BAG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell | GileadSciences,Inc. |